Roche net profit up 34 pct on cancer drug sales
235034
BASEL, Switzerland  - Net profit at Roche Holding AG  rose 34 percent to 9.17 billion Swiss francs ($7.33 billion) in 2006 due to strong sales of cancer treatments Herceptin and Avastin, just ahead of analysts' expectations.
535852
CVS Corp. , the No. 2 U.S. drugstore chain, posted higher quarterly profit on Thursday, driven by strong sales of prescription medications.
10796
Net profit in the fourth quarter rose to 753 million euros ($1.09 billion), helped by sales of the blood-thinner Plavix in the United States and cost-cutting measures, the company said.
410676
Swiss pharmaceutical giant Novartis on Thursday announced record earnings over the first nine months of the year, but third quarter profits fell 12 percent on sharper competition from generic drugs.
374731
Eli Lilly and Co  on Tuesday  said fourth-quarter profit rose on higher-than-expected sales  of its medicines, including strong demand for its newer  treatments for depression, diabetes and cancer.
365339
Pfizer Inc. , the world's biggest drugmaker, on Wednesday said third-quarter earnings rose on higher sales of key medicines.
681000
Novartis  missed  expectations with a 4 percent rise in second-quarter net income  to &#36;1.713 billion on Monday, as heavy charges from the Swiss  drug giant&#039;s acquisition of U.S. biotech firm Chiron weighed.
687968
German drug and chemical maker Bayer AG said Thursday it posted a third-quarter net profit of 34 million euros ($42.2 million), reversing losses from a year ago as a recovery in the chemical industry helped ...
448727
Pharmaceutical group Sanofi-Synthelabo said it had increased net profit in the first half of the year by 20.6 percent from the same period last year to 1.138 billion euros (1.38 billion dollars).
549877
The drug maker Schering-Plough Corporation said yesterday that its fourth-quarter profit surged 75 percent as strong sales of its cholesterol, arthritis and allergy medicines helped offset rising research and marketing spending.
229274
Genentech, the biotechnology company, posted a 41 percent increase in second-quarter profit on sales of its cancer drugs, continuing a positive earnings streak.
272056
The Swiss pharmaceuticals giant Roche, manufacturer of anti-flu drug Tamiflu, said its first-half net profit had increased by 37 percent to 4.54 billion Swiss francs (2.9 billion euros, 3.62 billion dollars).
740075
New clinical data showed Avastin  improved the chances of a removal of metastatic lesions in  patients with colorectal cancer, Swiss drugmaker Roche Holding  AG said on Monday.
617687
Roche (ROG.VX: Quote, Profile, Research) has filed for EU marketing approval for its Tarceva drug to treat advanced non-small cell lung cancer, the Swiss healthcare group said on Thursday, boosting its shares.
336336
BASEL, Switzerland  - Novartis AG's  fourth-quarter net profit fell 42 percent to $931 million, missing forecasts, hit by generic competition and a one-off restructuring charge, the Swiss drugmaker said on Thursday.
227799
Drugmakers Merck & Co.  and Schering-Plough Corp.  reported second-quarter results that handily topped Wall Street expectations on Monday, helped by increased sales of the cholesterol-lowering drugs they co-market and other medicines.
636969
Abbott Laboratories Inc. ABT.N on  Tuesday said its fourth-quarter profit rose 3.2 percent on  higher sales of its prescription drugs, including its popular  new treatment for rheumatoid arthritis, Humira.